Teleflex Incorporated Expected to Post FY2017 Earnings of $8.26 Per Share (TFX)

Teleflex Incorporated (NYSE:TFX) – Stock analysts at William Blair increased their FY2017 EPS estimates for Teleflex in a research report issued on Thursday. William Blair analyst B. Weinstein now anticipates that the medical technology company will post earnings of $8.26 per share for the year, up from their prior estimate of $8.12. William Blair also issued estimates for Teleflex’s FY2018 earnings at $9.55 EPS.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.91 by $0.13. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The business had revenue of $528.60 million for the quarter, compared to the consensus estimate of $518.98 million. During the same period in the prior year, the business posted $1.89 earnings per share. The company’s quarterly revenue was up 11.6% compared to the same quarter last year.

TRADEMARK VIOLATION NOTICE: “Teleflex Incorporated Expected to Post FY2017 Earnings of $8.26 Per Share (TFX)” was originally posted by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another site, it was illegally copied and republished in violation of United States & international copyright laws. The correct version of this article can be read at https://www.com-unik.info/2017/08/19/teleflex-incorporated-expected-to-post-fy2017-earnings-of-8-26-per-share-tfx-updated.html.

Other research analysts have also recently issued reports about the company. Zacks Investment Research cut Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, May 20th. Leerink Swann boosted their target price on Teleflex from $215.00 to $220.00 and gave the stock a “market perform” rating in a report on Friday, June 9th. Needham & Company LLC restated a “buy” rating and set a $224.00 target price on shares of Teleflex in a report on Friday, May 5th. Jefferies Group LLC restated a “buy” rating and set a $230.00 target price on shares of Teleflex in a report on Thursday, August 3rd. Finally, BidaskClub cut Teleflex from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $221.17.

Shares of Teleflex (NYSE TFX) opened at 214.60 on Monday. Teleflex has a 12 month low of $136.53 and a 12 month high of $216.77. The stock has a market capitalization of $9.65 billion, a P/E ratio of 44.54 and a beta of 1.05. The firm’s 50-day moving average price is $207.61 and its 200-day moving average price is $195.00.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 15th. Stockholders of record on Tuesday, August 15th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.63%. The ex-dividend date of this dividend is Friday, August 11th. Teleflex’s payout ratio is presently 26.00%.

In other news, Director Stephen K. M.D. Klasko sold 5,200 shares of Teleflex stock in a transaction that occurred on Monday, May 15th. The shares were sold at an average price of $193.56, for a total transaction of $1,006,512.00. Following the sale, the director now owns 12,880 shares of the company’s stock, valued at approximately $2,493,052.80. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Stuart A. Randle sold 2,500 shares of Teleflex stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $205.67, for a total transaction of $514,175.00. Following the sale, the director now directly owns 7,532 shares in the company, valued at approximately $1,549,106.44. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 8,300 shares of company stock worth $1,643,975. Corporate insiders own 2.39% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in the stock. Asset Planning Services Ltd. purchased a new stake in Teleflex during the first quarter valued at approximately $116,000. Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in Teleflex during the first quarter valued at approximately $155,000. OLD Mutual Customised Solutions Proprietary Ltd. raised its stake in Teleflex by 200.0% in the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 900 shares of the medical technology company’s stock valued at $174,000 after buying an additional 600 shares during the last quarter. Campbell & CO Investment Adviser LLC purchased a new stake in Teleflex during the second quarter valued at approximately $200,000. Finally, Harvey Capital Management Inc. purchased a new stake in Teleflex during the second quarter valued at approximately $207,000. 93.02% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Earnings History and Estimates for Teleflex (NYSE:TFX)

What are top analysts saying about Teleflex Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Teleflex Incorporated and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit